MedTrace Logo

A Study to Evaluate the Safety and Performance of the Vista Probe for Vitrectomy Surgery

NCT05689333 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 32

Last updated 2025-04-01

No results posted yet for this study

Summary

This is a prospective, single-arm, non-comparative, open-label, monocular, post approval study to assess safety and device performance of the Vista Vitrectomy Probe during vitrectomy surgery.

Conditions

  • Vitrectomy

Interventions

DEVICE

Vista Vitrectomy Probe

Vitrectomy will be performed through 27 GA Vista Ophthalmics vitrector

Sponsors & Collaborators

  • CBCC Global Research

    collaborator NETWORK

  • VISTA Ophthalmics

    lead INDUSTRY

Principal Investigators

  • Don Knowles · VISTA Ophthalmics

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-12-09
Primary Completion
2024-05-07
Completion
2024-05-07
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05689333 on ClinicalTrials.gov